Environmental Factor Index (EFI): A Novel Approach to Measure the Strength of Environmental Influence on DNA Methylation in Identical Twins

Overview

Journal Epigenomes

Date 2024 Nov 25

PMID 39584967

Authors

Yoichi Takenaka

Osaka Twin Research Group

Mikio Watanabe

Affiliations

Soon will be listed here.

Abstract

Background/objectives: The dynamic interaction between genomic DNA, epigenetic modifications, and phenotypic traits was examined in identical twins. Environmental perturbations can induce epigenetic changes in DNA methylation, influencing gene expression and phenotypes. Although DNA methylation mediates gene-environment correlations, the quantitative effects of external factors on DNA methylation remain underexplored. This study aimed to quantify these effects using a novel approach.

Methods: A cohort study was conducted on healthy monozygotic twins to evaluate the influence of environmental stimuli on DNA methylation. We developed the Environmental Factor Index (EFI) to identify methylation sites showing statistically significant changes in response to environmental stimuli. We analyzed the identified sites for associations with disorders, DNA methylation markers, and CpG islands.

Results: The EFI identified methylation sites that exhibited significant associations with genes linked to various disorders, particularly cancer. These sites were overrepresented on CpG islands compared to other genomic features, highlighting their regulatory importance.

Conclusions: The EFI is a valuable tool for understanding the molecular mechanisms underlying disease pathogenesis. It provides insights into the development of preventive and therapeutic strategies and offers a new perspective on the role of environmental factors in epigenetic regulation.

Citing Articles

Epigenetic Mechanisms of Endocrine-Disrupting Chemicals in Breast Cancer and Their Impact on Dietary Intake.

Singh D J Xenobiot. 2025; 15(1.

PMID: 39846533 PMC: 11755457. DOI: 10.3390/jox15010001.

References

Fallet M, Blanc M, Di Criscio M, Antczak P, Engwall M, Bosagna C . Present and future challenges for the investigation of transgenerational epigenetic inheritance. Environ Int. 2023; 172:107776. DOI: 10.1016/j.envint.2023.107776. View

Yin Y, Morgunova E, Jolma A, Kaasinen E, Sahu B, Khund-Sayeed S . Impact of cytosine methylation on DNA binding specificities of human transcription factors. Science. 2017; 356(6337). PMC: 8009048. DOI: 10.1126/science.aaj2239. View

Lichtenstein P, Holm N, Verkasalo P, Iliadou A, Kaprio J, Koskenvuo M . Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000; 343(2):78-85. DOI: 10.1056/NEJM200007133430201. View

Edris A, den Dekker H, Melen E, Lahousse L . Epigenome-wide association studies in asthma: A systematic review. Clin Exp Allergy. 2019; 49(7):953-968. DOI: 10.1111/cea.13403. View

Bell J, Saffery R . The value of twins in epigenetic epidemiology. Int J Epidemiol. 2012; 41(1):140-50. DOI: 10.1093/ije/dyr179. View

Bell J, Spector T . A twin approach to unraveling epigenetics. Trends Genet. 2011; 27(3):116-25. PMC: 3063335. DOI: 10.1016/j.tig.2010.12.005. View

Kim M, Lee J, Sidransky D . DNA methylation markers in colorectal cancer. Cancer Metastasis Rev. 2010; 29(1):181-206. DOI: 10.1007/s10555-010-9207-6. View

Bird A . DNA methylation patterns and epigenetic memory. Genes Dev. 2002; 16(1):6-21. DOI: 10.1101/gad.947102. View

Cortessis V, Thomas D, Levine A, Breton C, Mack T, Siegmund K . Environmental epigenetics: prospects for studying epigenetic mediation of exposure-response relationships. Hum Genet. 2012; 131(10):1565-89. PMC: 3432200. DOI: 10.1007/s00439-012-1189-8. View

10.

Tanzer M, Balluff B, Distler J, Hale K, Leodolter A, Rocken C . Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions. PLoS One. 2010; 5(2):e9061. PMC: 2816214. DOI: 10.1371/journal.pone.0009061. View

11.

Xu W, Xu M, Wang L, Zhou W, Xiang R, Shi Y . Integrative analysis of DNA methylation and gene expression identified cervical cancer-specific diagnostic biomarkers. Signal Transduct Target Ther. 2019; 4:55. PMC: 6908647. DOI: 10.1038/s41392-019-0081-6. View

12.

Maunakea A, Chepelev I, Cui K, Zhao K . Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition. Cell Res. 2013; 23(11):1256-69. PMC: 3817542. DOI: 10.1038/cr.2013.110. View

13.

Bechtel W, McGoohan S, Zeisberg E, Muller G, Kalbacher H, Salant D . Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med. 2010; 16(5):544-50. PMC: 3106179. DOI: 10.1038/nm.2135. View

14.

Sigin V, Kalinkin A, Kuznetsova E, Simonova O, Chesnokova G, Litviakov N . DNA methylation markers panel can improve prediction of response to neoadjuvant chemotherapy in luminal B breast cancer. Sci Rep. 2020; 10(1):9239. PMC: 7280523. DOI: 10.1038/s41598-020-66197-1. View

15.

Houseman E, Accomando W, Koestler D, Christensen B, Marsit C, Nelson H . DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics. 2012; 13:86. PMC: 3532182. DOI: 10.1186/1471-2105-13-86. View

16.

Yan P, Yang X, Wang J, Wang S, Ren H . A novel CpG island methylation panel predicts survival in lung adenocarcinomas. Oncol Lett. 2019; 18(2):1011-1022. PMC: 6607393. DOI: 10.3892/ol.2019.10431. View

17.

Davegardh C, Garcia-Calzon S, Bacos K, Ling C . DNA methylation in the pathogenesis of type 2 diabetes in humans. Mol Metab. 2018; 14:12-25. PMC: 6034041. DOI: 10.1016/j.molmet.2018.01.022. View

18.

Rappaport N, Twik M, Plaschkes I, Nudel R, Iny Stein T, Levitt J . MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search. Nucleic Acids Res. 2016; 45(D1):D877-D887. PMC: 5210521. DOI: 10.1093/nar/gkw1012. View

19.

Horvath S, Raj K . DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat Rev Genet. 2018; 19(6):371-384. DOI: 10.1038/s41576-018-0004-3. View

20.

Egger G, Liang G, Aparicio A, Jones P . Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004; 429(6990):457-63. DOI: 10.1038/nature02625. View